May 21st, 2014
The Risk-Prediction Conundrum: Individual Risk vs. Population Risk
John W McEvoy, MB BCh BAO
John W. McEvoy discusses his recent review article about how to interpret cardiac risk for an individual patient when risk estimates are more accurate for populations of patients.
June 6th, 2012
Selections from Richard Lehman’s Literature Review: June 6th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include cIMT and clinical outcome, CVD risk scores, door- vs. onset-to-balloon times, and dark chocolate consumption in people with high CVD risk.
NEJM Journal Watch — Recent Cardiology Articles- Is Diltiazem Safe in Patients with AF Taking Apixaban or Rivaroxaban?
- Does Lowering High Childhood Lipid Levels Prevent Adverse Cardiovascular Events in Adulthood?
- Self-Expanding Supraannular Valve vs. Balloon-Expandable Valve in TAVR for Small Aortic Annulus
- A New TAVR Prosthesis for Aortic Regurgitation Shows Promise
- Aprocitentan, a Newly Approved Drug for Resistant Hypertension